DTIL
PRECISION BIOSCIENCES INC
Key Financials
Revenue
$34.3M
↓ 50.1%
Operating Income
$-52148000
↓ 99.3%
EPS (Diluted)
$-3.56
↓ 442.3%
Total Assets
$154.4M
↑ 13.2%
Cash & Equivalents
$110.8M
↑ 29.0%
Total Liabilities
$62.2M
↓ 22.3%
Shareholders' Equity
$92.2M
↑ 63.6%
Long-term Debt
$22.2M
0.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 5/5/2026 | View on SEC |
| 8-K | 5/5/2026 | View on SEC |
| SCHEDULE 13G/A | 4/15/2026 | View on SEC |
| ARS | 4/8/2026 | View on SEC |
| DEFA14A | 4/8/2026 | View on SEC |
| DEF 14A | 4/8/2026 | View on SEC |
| PRE 14A | 3/27/2026 | View on SEC |
| 8-K | 3/17/2026 | View on SEC |
| 10-K | 3/12/2026 | View on SEC |
| 8-K | 3/12/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | DTIL |
| Company Name | PRECISION BIOSCIENCES INC |
| CIK | 1357874 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 919-314-5512 |